Showing results (41-50 of 80) with videos related to
Sort By:
Pageof 8
Yeast (Chichester, England)|July 31, 2010
NY-ESO-1 protein glycosylated by yeast induces enhanced immune responsesAndreas Wadle, Axel Mischo, Sabine Strahl, et al.Leukemia & Lymphoma|October 20, 2021
Significant reduced loss of bone mineral density after four vs. six cycles of R-CHOP: an analysis of the FLYER-trialDominic Kaddu-Mulindwa, Vadim Lesan, Christian Berdel, et al.Proceedings of the National Academy of Sciences of the United States of America|March 25, 2009
Rational development of high-affinity T-cell receptor-like antibodiesGuillaume Stewart-Jones, Andreas Wadle, Anja Hombach, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2012
TET2 mutations in acute myeloid leukemia (AML): results from a comprehensive genetic and clinical analysis of the AML study groupVerena I Gaidzik, Peter Paschka, Daniela Späth, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2014
Optimization of rituximab for the treatment of diffuse large B-cell lymphoma (II): extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the german high-grade non-Hodgkin lymphoma study groupMichael Pfreundschuh, Viola Poeschel, Samira Zeynalova, et al.European Journal of Nuclear Medicine and Molecular Imaging|April 30, 2021
FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trialsDominic Kaddu-Mulindwa, Bettina Altmann, Gerhard Held, et al.British Journal of Haematology|October 10, 2017
Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patientsMichael Pfreundschuh, Niels Murawski, Samira Zeynalova, et al.Genome Research|November 18, 2025
Integration of high-throughput proteomic data and complementary omics layers with PriOmicsRobin Kosch, Katharina Limm, Annette M Staiger, et al.Blood Advances|January 30, 2023
Central nervous system relapse in younger patients with diffuse large B-cell lymphoma: a LYSA and GLA/DSHNHL analysisCatherine Thieblemont, Bettina Altmann, Fabian Frontzek, et al.Blood|December 4, 2010
The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AMLSabine Kayser, Konstanze Döhner, Jürgen Krauter, et al.Pageof 8